A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agentsGERTZ, Barry J; KRUPA, David; BOLOGNESE, James A et al.Current medical research and opinion. 2002, Vol 18, Num 2, pp 82-91, issn 0300-7995Article

Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with Rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (Ibuprofen, Diclofenac, and Nabumetone)REICIN, Alise S; SHAPIRO, Deborah; SPERLING, Rhoda S et al.The American journal of cardiology. 2002, Vol 89, Num 2, pp 204-209, issn 0002-9149Article

Selective COX-2 inhibition and cardiovascular effects: A review of the rofecoxib development programWEIR, Matthew R; SPORTING, Rhoda S; REICIN, Alise et al.The American heart journal. 2003, Vol 146, Num 4, pp 591-604, issn 0002-8703, 14 p.Article

Serious lower gastrointestinal clinical events with nonselective NSAID or coxib useLAINE, Loren; CONNORS, Laurine G; REICIN, Alise et al.Gastroenterology (New York, NY. 1943). 2003, Vol 124, Num 2, pp 288-292, issn 0016-5085, 5 p.Article

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritisLAINE, Loren; BOMBARDIER, Claire; HAWKEY, Christopher J et al.Gastroenterology (New York, NY. 1943). 2002, Vol 123, Num 4, pp 1006-1012, issn 0016-5085Article

Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathyTSOUKAS, Christos; EYSTER, M. Elaine; SHINGO, Sumiko et al.Blood. 2006, Vol 107, Num 5, pp 1785-1790, issn 0006-4971, 6 p.Article

Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trialsCURTIS, Sean P; NG, Jennifer; QINFEN YU et al.Clinical therapeutics. 2004, Vol 26, Num 1, pp 70-83, issn 0149-2918, 14 p.Article

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxibKONSTAM, Marvin A; WEIR, Matthew R; REICIN, Alise et al.Circulation (New York, N.Y.). 2001, Vol 104, Num 19, pp 2280-2288, issn 0009-7322Article

Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthmaREICIN, Alise; WHITE, Richard; WEINSTEIN, Steven F et al.Archives of internal medicine (1960). 2000, Vol 160, Num 16, pp 2481-2488, issn 0003-9926Article

N-Terminal Propeptide of Type III Procollagen as a Biomarker of Anabolic Response to Recombinant Human GH and TestosteroneBHASIN, Shalender; JIAXIU HE, E; CASTANEDA-SCEPPA, Carmen et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 11, pp 4224-4233, issn 0021-972X, 10 p.Article

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritisBOMBARDIER, Claire; LAINE, Loren; KVIEN, Tore K et al.The New England journal of medicine. 2000, Vol 343, Num 21, pp 1520-1528, issn 0028-4793Article

fMRI investigation of the effect of local and systemic lidocaine on noxious electrical stimulation-induced activation in spinal cordFUQIANG ZHAO; WILLIAMS, Mangay; WELSH, Denise C et al.Pain (Amsterdam). 2009, Vol 145, Num 1-2, pp 110-119, issn 0304-3959, 10 p.Article

Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery : A randomized, double-blind, placebo-controlled studyRASMUSSEN, G. Lynn; MALMSTROM, Kerstin; BOURNE, Michael H et al.Anesthesia and analgesia. 2005, Vol 101, Num 4, pp 1104-1111, issn 0003-2999, 8 p.Article

Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis : A randomized, double-blind, placebo-controlled trialWIESENHUTTER, Craig W; BOICE, Judith A; KO, Amy et al.Mayo Clinic proceedings. 2005, Vol 80, Num 4, pp 470-479, issn 0025-6196, 10 p.Article

Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis : A 12-week randomized controlled clinical trial with a 52-week open-label extensionREIFF, Andreas; LOVELL, Daniel J; GIANNINI, Edward H et al.Journal of rheumatology. 2006, Vol 33, Num 5, pp 985-995, issn 0315-162X, 11 p.Article

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis : Results of a fifty-two-week, randomized, controlled studyVAN DER HEIJDE, Désirée; BARAF, Herbert S. B; DOUGADOS, Maxime et al.Arthritis and rheumatism. 2005, Vol 52, Num 4, pp 1205-1215, issn 0004-3591, 11 p.Article

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-Term (MEDAL) programme : a randomised comparison. CommentaryGARCIA RODRIGUEZ, Luis Alberto; PATRIQNANI, Paola; WEINBLATT, Michael E et al.Lancet (British edition). 2006, Vol 368, Num 9549, issn 0140-6736, 1745-1747,1771-1781 [14 p.]Article